首页> 外国专利> PREPARATION OF BLOOD-PLASMA KALLIKREIN AND DETERMINATION OF BLOOD-PLASMA PREKALLIKREIN

PREPARATION OF BLOOD-PLASMA KALLIKREIN AND DETERMINATION OF BLOOD-PLASMA PREKALLIKREIN

机译:血浆血浆激肽释放酶的制备和测定

摘要

PURPOSE:To prepare the titled compound useful as a medicine for cardio-vascular system, easily, by adding an activating agent such as kaolin to the blood-plasma of mammals adjusted to a specific pH value, thereby activating the prekallikrein and at the same time adsorbing the activated kallikrein to the activating agent, and then eluting the adsorbed kallikrein with a specific solution. CONSTITUTION:Human or mammalian blood-plasma is mixed with a buffer solution [e.g. equal volume of 0.1M phosphate buffer solution (pH 6.0), etc.] to adjust the pH of the mixture of to 6.5. An activating agent such as kaolin or Celite is added to the mixture and stirred thoroughly at a low temperature to activate the prekallikrein. The amount of the activating agent is =15mg/1ml of the blood- plasma. The activated kallikrein is simultaneously adsorbed to the activating agent. The adsorbed kallikrein is eluted with a protamine solution prepared by dissolving 0.5-4mg of protamine in 1ml of 0.02M tris-hydrochloric acid buffer solution (pH 8.0) to obtain the blood-plasma kallikrein in high efficiency. The kallikrein plays an important role in quinine, coagulation or adenolytic system for maintaining the homeostatis.
机译:用途:要制备适合用作心血管系统药物的标题化合物,只需在调节至特定pH值的哺乳动物的血浆中加入活化剂(如高岭土),即可同时激活前激肽释放酶,并同时活化将活化的激肽释放酶吸附到活化剂上,然后用特定溶液洗脱吸附的激肽释放酶。组成:人类或哺乳动物的血浆与缓冲溶液混合[例如等体积的0.1M磷酸盐缓冲溶液(pH 6.0等),将混合物的pH调节至6.5。将诸如高岭土或硅藻土的活化剂添加至混合物中,并在低温下充分搅拌以活化前激肽释放酶。活化剂的量为血浆的≥15mg/ 1ml。活化激肽释放酶同时吸附到活化剂上。用将0.5-4mg鱼精蛋白溶解在1ml 0.02M tris-盐酸缓冲溶液(pH 8.0)中制备的鱼精蛋白溶液洗脱吸附的激肽释放酶,从而高效获得血浆激肽释放酶。激肽释放酶在奎宁,凝血或腺苷酸维持体内稳态中起着重要作用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号